title: Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene.
abstract: Autosomal dominant polycystic kidney disease (ADPKD) is common and is a major cause of renal failure. Although the genetics of ADPKD are well known and have led to the discovery of polycystins, a new protein family, the pathogenesis of the disease remains largely unknown. Recent studies have indicated that the beta-catenin signaling pathway is one of the targets of the transduction pathway controlled by the polycystins. We have generated transgenic mice that overproduce an oncogenic form of beta-catenin in the epithelial cells of the kidney. These mice developed severe polycystic lesions soon after birth that affected the glomeruli, proximal, distal tubules and collecting ducts. The phenotype of these mice mimicked the human ADPKD phenotype. Cyst formation was associated with an increase in cell proliferation and apoptosis. The cell proliferation and apoptotic indexes was increased 4-5-fold and 3-4-fold, respectively, in cystic tubules of the transgenic mice compared to that of littermate controls. Our findings provide experimental genetic evidence that activation of the Wnt/beta-catenin signaling pathway causes polycystic kidney disease and support the view that dysregulation of the Wnt/beta-catenin signaling is involved in its pathogenesis.
authors.affiliation: INSERM U129, ICGM, 24 rue du Faubourg St Jacques, 75014 Paris, France.
authors.forename: S
authors.initials: S
authors.lastname: Saadi-Kheddouci
authors.forename: D
authors.initials: D
authors.lastname: Berrebi
authors.forename: B
authors.initials: B
authors.lastname: Romagnolo
authors.forename: F
authors.initials: F
authors.lastname: Cluzeaud
authors.forename: M
authors.initials: M
authors.lastname: Peuchmaur
authors.forename: A
authors.initials: A
authors.lastname: Kahn
authors.forename: A
authors.initials: A
authors.lastname: Vandewalle
authors.forename: C
authors.initials: C
authors.lastname: Perret
mesh_terms: D000818:Animals; D002455:Cell Division; D019938:Cyclin D1 / Q000096:biosynthesis / Q000235:genetics; D003598:Cytoskeletal Proteins / Q000235:genetics* / Q000502:physiology*; D004847:Epithelial Cells / Q000737:chemistry; D007668:Kidney / Q000378:metabolism / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic; D009154:Mutation; D009399:Nephrons / Q000473:pathology; D007690:Polycystic Kidney Diseases / Q000209:etiology* / Q000473:pathology; D016271:Proto-Oncogene Proteins c-myc / Q000096:biosynthesis / Q000235:genetics; D012333:RNA, Messenger / Q000096:biosynthesis; D000254:Sodium-Potassium-Exchanging ATPase / Q000032:analysis; D015534:Trans-Activators; D051176:beta Catenin
chemical_list: C495267:CTNNB1 protein, mouse; D003598:Cytoskeletal Proteins; D016271:Proto-Oncogene Proteins c-myc; D012333:RNA, Messenger; D015534:Trans-Activators; D051176:beta Catenin; D019938:Cyclin D1; D000254:Sodium-Potassium-Exchanging ATPase